HAP Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $73.3K | Sell |
87,900
-25,700
| -23% | -$634K | 0.01% | 548 |
|
|
2025
Q2 | $47.6K | Sell |
113,600
-18,500
| -14% | -$431K | ﹤0.01% | 521 |
|
|
2025
Q1 | $76.2K | Sell |
132,100
-38,000
| -22% | -$994K | 0.01% | 423 |
|
|
2024
Q4 | $112K | Sell |
170,100
-7,000
| -4% | -$190K | 0.01% | 385 |
|
|
2024
Q3 | $255K | Sell |
177,100
-2,200
| -1% | -$64.2K | 0.03% | 277 |
|
|
2024
Q2 | $223K | Buy |
179,300
+83,900
| +88% | +$2.31M | 0.03% | 269 |
|
|
2024
Q1 | $126K | Buy |
95,400
+6,100
| +7% | +$169K | 0.01% | 334 |
|
|
2023
Q4 | $49.5K | Buy |
89,300
+30,300
| +51% | +$916K | 0.01% | 454 |
|
|
2023
Q3 | $16.8K | Sell |
59,000
-6,500
| -10% | -$230K | ﹤0.01% | 699 |
|
|
2023
Q2 | $4.66K | Buy |
65,500
+8,500
| +15% | +$331K | ﹤0.01% | 933 |
|
|
2023
Q1 | $36K | Sell |
57,000
-60,600
| -52% | -$2.62M | 0.01% | 616 |
|
|
2022
Q4 | $282K | Sell |
117,600
-60,900
| -34% | -$2.92M | 0.03% | 396 |
|
|
2022
Q3 | $130K | Buy |
178,500
+28,000
| +19% | +$1.36M | 0.01% | 726 |
|
|
2022
Q2 | $898K | Sell |
150,500
-123,100
| -45% | -$6.27M | 0.04% | 318 |
|
|
2022
Q1 | $1.06M | Sell |
273,600
-194,500
| -42% | -$10.1M | 0.04% | 333 |
|
|
2021
Q4 | $4M | Buy |
468,100
+26,600
| +6% | +$1.32M | 0.11% | 162 |
|
|
2021
Q3 | $836K | Sell |
441,500
-122,100
| -22% | -$5.41M | 0.03% | 516 |
|
|
2021
Q2 | $565K | Buy |
563,600
+371,000
| +193% | +$14.4M | 0.02% | 616 |
|
|
2021
Q1 | $222K | Sell |
192,600
-295,700
| -61% | -$10.5M | 0.01% | 733 |
|
|
2020
Q4 | $482K | Buy |
488,300
+171,468
| +54% | +$6.29M | 0.01% | 645 |
|
|
2020
Q3 | $400K | Buy |
316,832
+61,448
| +24% | +$2.15M | 0.02% | 456 |
|
|
2020
Q2 | $132K | Buy |
255,384
+163,475
| +178% | +$5.55M | 0.01% | 794 |
|
|
2020
Q1 | $45K | Buy |
91,909
+17,286
| +23% | +$589K | ﹤0.01% | 792 |
|
|
2019
Q4 | $79K | Sell |
74,623
-37,733
| -34% | -$1.34M | ﹤0.01% | 607 |
|
|
2019
Q3 | $52K | Buy |
112,356
+56,810
| +102% | +$2.07M | ﹤0.01% | 726 |
|
|
2019
Q2 | $86K | Buy |
55,546
+34,571
| +165% | +$1.37M | 0.01% | 635 |
|
|
2019
Q1 | $13K | Sell |
20,975
-69,880
| -77% | -$2.8M | ﹤0.01% | 895 |
|
|
2018
Q4 | $287K | Buy |
90,855
+22,767
| +33% | +$945K | 0.02% | 479 |
|
|
2018
Q3 | $350K | Buy |
68,088
+316
| +0.5% | +$12.2K | 0.02% | 352 |
|
|
2018
Q2 | $52K | Sell |
67,772
-499,069
| -88% | -$17.1M | ﹤0.01% | 673 |
|
|
2018
Q1 | $33K | Buy |
566,841
+530,267
| +1,450% | +$18.2M | ﹤0.01% | 706 |
|
|
2017
Q4 | $34K | Sell |
36,574
-1,475
| -4% | -$50.3K | ﹤0.01% | 721 |
|
|
2017
Q3 | $66K | Buy |
38,049
+15,915
| +72% | +$512K | ﹤0.01% | 623 |
|
|
2017
Q2 | $22K | Buy |
22,134
+5,375
| +32% | +$170K | ﹤0.01% | 781 |
|
|
2017
Q1 | $31K | Sell |
16,759
-73,780
| -81% | -$2.33M | ﹤0.01% | 763 |
|
|
2016
Q4 | $50K | Buy |
90,539
+33,412
| +58% | +$1.02M | ﹤0.01% | 646 |
|
|
2016
Q3 | $9K | Sell |
57,127
-332,221
| -85% | -$11.1M | ﹤0.01% | 993 |
|
|
2016
Q2 | $830K | Sell |
389,348
-99,919
| -20% | -$3.19M | 0.05% | 246 |
|
|
2016
Q1 | $100K | Buy |
489,267
+137,442
| +39% | +$3.93M | 0.01% | 462 |
|
|
2015
Q4 | $47K | Buy |
351,825
+262,762
| +295% | +$8.27M | ﹤0.01% | 648 |
|
|
2015
Q3 | $35K | Buy |
89,063
+17,180
| +24% | +$551K | ﹤0.01% | 737 |
|
|
2015
Q2 | $51K | Sell |
71,883
-8,959
| -11% | -$292K | ﹤0.01% | 657 |
|
|
2015
Q1 | $133K | Sell |
80,842
-357,622
| -82% | -$11.4M | 0.01% | 492 |
|
|
2014
Q4 | $488K | Buy |
438,464
+62,397
| +17% | +$1.79M | 0.02% | 453 |
|
|
2014
Q3 | $277K | Sell |
376,067
-2,214
| -0.6% | -$62.1K | 0.01% | 545 |
|
|
2014
Q2 | $362K | Buy |
+378,281
| New | +$10.8M | 0.01% | 501 |
|
|
2014
Q1 | – | Sell |
-166,321
| Closed | -$125K | – | 1304 |
|
|
2013
Q4 | $125K | Buy |
+166,321
| New | +$4.84M | ﹤0.01% | 772 |
|
Other funds holding PFE
HAP Trading's PFE Position: Q3 2025 in Review
HAP Trading sold out of Pfizer (PFE) in Q3 2025, closing a stake of 61,326 shares — an estimated $1.51M sold.
HAP Trading first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $182M in Q2 2013. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- HAP Trading reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 61,326 Pfizer shares in Q3 2025, an estimated $1.51M.
- HAP Trading first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
- HAP Trading's Pfizer position peaked at $182M in Q2 2013.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.